Black Diamond Therapeutics, Inc. (BDTX) Earnings
|
Expand Research on BDTX
| Next EPS Date | 8/6/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +459.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | -$0.16 | -$0.19 | +$0.03 | N/A | N/A | N/A |  | | Details | |
| 3/16/26 |
Q425 | -$0.27 | -$0.17 | -$0.10 | N/A | N/A | N/A | | | Details | |
| 11/10/25 |
Q325 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/25 |
Q225 | N/A | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/25 |
Q125 | $0.98 | $0.05 | +$0.93 | $70M | $28M | N/A | | | Details | |
| 5/9/25 |
Q125 | N/A | $0.05 | N/A | N/A | $28M | N/A | N/A | N/A | ||
| 5/7/25 |
Q125 | N/A | $0.05 | N/A | N/A | $28M | N/A | N/A | N/A |
